Trade Summary

3 days ago, Schwab Andrew J., serving as Dir at Camp4 Therapeutics Corp (CAMP), sold 191,865 shares at $4.59 per share, for a total transaction value of $879,718.72. Following this transaction, Schwab Andrew J. now holds 2,433,280 shares of CAMP.

This sale represents a 7.31% decrease in Schwab Andrew J.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, August 19, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 21, 2026 at 4:59 PM ET, 2 days after the trade was made.

Camp4 Therapeutics Corp operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.